The outcome of short-term low-dose aspirin treatment in Kawasaki disease based on inflammatory markers

PURPOSE: Previously, Kawasaki disease (KD) treatment with low-dose aspirin was administered for 6–8 weeks after the acute phase. However, inflammatory marker levels normalize before 6–8 weeks. In this study, we aimed to investigate the clinical outcome of short-term low-dose aspirin treatment based...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Jae Won, Kim, Ji Mok, Kil, Hong Ryang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pediatric Society 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309321/
https://www.ncbi.nlm.nih.gov/pubmed/28203257
http://dx.doi.org/10.3345/kjp.2017.60.1.24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309321/
https://www.ncbi.nlm.nih.gov/pubmed/28203257
http://dx.doi.org/10.3345/kjp.2017.60.1.24

Ejemplares similares